Risk of amputation associated with sodium-glucose co-transporter 2 inhibitors: a meta-analysis of five randomized controlled trials
S Miyashita, T Kuno, H Takagi, T Sugiyama… - Diabetes Research and …, 2020 - Elsevier
Amputation has been known to be a rare adverse event of sodium glucose co-transporter-2
(SGLT2) inhibitors. It remains unclear whether the SGLT2 inhibitor as a class or specific …
(SGLT2) inhibitors. It remains unclear whether the SGLT2 inhibitor as a class or specific …
Risk of amputation associated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of five randomized controlled trials
S Miyashita, T Kuno, H Takagi… - Diabetes Research …, 2020 - keio.elsevierpure.com
Amputation has been known to be a rare adverse event of sodium glucose co-transporter-2
(SGLT2) inhibitors. It remains unclear whether the SGLT2 inhibitor as a class or specific …
(SGLT2) inhibitors. It remains unclear whether the SGLT2 inhibitor as a class or specific …
Risk of amputation associated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of five randomized controlled trials
S Miyashita, T Kuno, H Takagi… - Diabetes …, 2020 - diabetesresearchclinicalpractice …
Amputation has been known to be a rare adverse event of sodium glucose co-transporter-2
(SGLT2) inhibitors. It remains unclear whether the SGLT2 inhibitor as a class or specific …
(SGLT2) inhibitors. It remains unclear whether the SGLT2 inhibitor as a class or specific …
Risk of amputation associated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of five randomized controlled trials
S Miyashita, T Kuno, H Takagi… - Diabetes research …, 2020 - pubmed.ncbi.nlm.nih.gov
Amputation has been known to be a rare adverse event of sodium glucose co-transporter-2
(SGLT2) inhibitors. It remains unclear whether the SGLT2 inhibitor as a class or specific …
(SGLT2) inhibitors. It remains unclear whether the SGLT2 inhibitor as a class or specific …
Risk of amputation associated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of five randomized controlled trials.
S Miyashita, T Kuno, H Takagi, T Sugiyama… - … and Clinical Practice, 2020 - europepmc.org
Amputation has been known to be a rare adverse event of sodium glucose co-transporter-2
(SGLT2) inhibitors. It remains unclear whether the SGLT2 inhibitor as a class or specific …
(SGLT2) inhibitors. It remains unclear whether the SGLT2 inhibitor as a class or specific …
Risk of amputation associated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of five randomized controlled trials
S Miyashita, T Kuno, H Takagi… - Diabetes Research …, 2020 - keio.elsevierpure.com
抄録 Amputation has been known to be a rare adverse event of sodium glucose co-
transporter-2 (SGLT2) inhibitors. It remains unclear whether the SGLT2 inhibitor as a class …
transporter-2 (SGLT2) inhibitors. It remains unclear whether the SGLT2 inhibitor as a class …